Clinical Trial Update: Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the bioavailability and the effect of food on two formulations of Afuresertib in cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Afuresertib (afuresertib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED